BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3021166)

  • 1. Origin of differences of inhibitory potency of cardiac glycosides in Na+/K+-transporting ATPase from human cardiac muscle, human brain cortex and guinea-pig cardiac muscle.
    Schönfeld W; Schönfeld R; Menke KH; Weiland J; Repke KR
    Biochem Pharmacol; 1986 Oct; 35(19):3221-31. PubMed ID: 3021166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lead structure in cardiac glycosides is 5 beta, 14 beta-androstane-3 beta 14-diol.
    Schönfeld W; Weiland J; Lindig C; Masnyk M; Kabat MM; Kurek A; Wicha J; Repke KR
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):414-26. PubMed ID: 4033807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation between isoforms of Na+/K+-transporting atpase from human and guinea-pig muscle through use of digitalis derivatives as analytical probes.
    Schön R; Weiland J; Megges R; Repke KR
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Mar; 351(3):282-92. PubMed ID: 7609782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
    Brown L; Erdmann E; Thomas R
    Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
    Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
    J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by digoxin and SC4453 of (Na+ + K+)-ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.
    Godfraind T; Tona Lutete DN
    Eur J Pharmacol; 1979 Dec; 60(4):329-36. PubMed ID: 230981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thermodynamic essence of the reversible inactivation of Na+/K+-transporting ATPase by various digitalis derivatives is relaxation of enzyme conformational energy.
    Beer J; Kunze R; Herrmann I; Portius HJ; Mirsalichova NM; Abubakirov NK; Repke KR
    Biochim Biophys Acta; 1988 Jan; 937(2):335-46. PubMed ID: 2827773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential suitability of Na+/K(+)-transporting ATPase in pre-screens for anti-cancer agents.
    Repke KR; Schön R; Megges R; Weiland J; Nissen E; Matthes E
    Anticancer Drug Des; 1995 Mar; 10(2):177-87. PubMed ID: 7710638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides.
    Tawfik H; Fox AA; Greeff K
    Biochem Pharmacol; 1985 Jul; 34(14):2541-7. PubMed ID: 2990491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of derivation on the lipophilicity and inhibitory actions of cardiac glycosides on myocardial Na+-K+-ATPase.
    Dzimiri N; Fricke U; Klaus W
    Br J Pharmacol; 1987 May; 91(1):31-8. PubMed ID: 3036289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of cardiac steroids having a doubly linked sugar and related compounds for the inhibition of Na+,K+-adenosine triphosphatase.
    Shimada K; Ishii N; Ohishi K; Ro JS; Nambara T
    J Pharmacobiodyn; 1986 Sep; 9(9):755-9. PubMed ID: 3025406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of progesterone derivatives with the digitalis target enzyme: impact of glycosidation on inhibitory potency.
    Weiland J; Schönfeld W; Menke KH; Repke KR
    Pharmacol Res; 1991 Jan; 23(1):27-32. PubMed ID: 1710800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cardiac glycosides on the Na+ pump current-voltage relationship of isolated rat and guinea-pig heart cells.
    Hermans AN; Glitsch HG; Verdonck F
    J Physiol; 1994 Dec; 481 ( Pt 2)(Pt 2):279-91. PubMed ID: 7738826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+ -ATPase.
    Chen RJ; Chung TY; Li FY; Yang WH; Jinn TR; Tzen JT
    Acta Pharmacol Sin; 2010 Jun; 31(6):696-702. PubMed ID: 20523340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to cardiac glycosides of (Na + K) ATPase prepared from human heart, guinea-pig heart and guinea-pig brain.
    De Pover A; Godfraind T
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):339-41. PubMed ID: 134678
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of 16 beta formylation on Na, K-ATPase inhibition by cardiac glycosides.
    De Pover A; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):135-9. PubMed ID: 6296702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of human erythrocyte Na+/K+ ATPase by cardiac glycosides and by a mammalian digitalis like factor.
    Balzan S; D'Urso G; Ghione S; Martinelli A; Montali U
    Life Sci; 2000 Sep; 67(16):1921-8. PubMed ID: 11072868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.